These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Value of uroplakin III in distinguishing variants of primary bladder urothelial carcinoma from malignancy metastatic to the urinary bladder. Klopfer K; Delahunt B; Adamson M; Samaratunga H Anticancer Res; 2014 Nov; 34(11):6779-84. PubMed ID: 25368291 [TBL] [Abstract][Full Text] [Related]
4. Giant cell carcinoma of the urinary bladder : Clinicopathologic analysis and oncological outcomes. Portugal-Gaspar F; Lopez-Beltran A; Paner GP; Blanca A; Gómez EG; Montironi R; Cimadamore A; Bilé A; Volavšek M; Cheng L Virchows Arch; 2024 Sep; 485(3):535-546. PubMed ID: 39023556 [TBL] [Abstract][Full Text] [Related]
5. Pleomorphic giant cell carcinoma of prostate: Rare tumor with unique clinicopathological, immunohistochemical, and molecular features. El-Zaatari ZM; Thomas JS; Divatia MK; Shen SS; Ayala AG; Monroig-Bosque P; Shehabeldin A; Ro JY Ann Diagn Pathol; 2021 Jun; 52():151719. PubMed ID: 33640702 [TBL] [Abstract][Full Text] [Related]
6. [Plasmacytoid urothelial carcinoma of the urinary bladder: a clinicopathologic study of 16 cases]. Zhang W; Jiang YX; Liu Y; Yu WJ; Zhao H; Li YJ Zhonghua Bing Li Xue Za Zhi; 2013 Jul; 42(7):433-7. PubMed ID: 24246859 [TBL] [Abstract][Full Text] [Related]
7. Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study. Samaratunga H; Khoo K Histopathology; 2004 Jul; 45(1):55-64. PubMed ID: 15228444 [TBL] [Abstract][Full Text] [Related]
8. Clear cell carcinoma of the urinary bladder: a report and comparison of four tumors of mullerian origin and nine of probable urothelial origin with discussion of histogenesis and diagnostic problems. Oliva E; Amin MB; Jimenez R; Young RH Am J Surg Pathol; 2002 Feb; 26(2):190-7. PubMed ID: 11812940 [TBL] [Abstract][Full Text] [Related]
9. Recently described and unusual variants of urothelial carcinoma of the urinary bladder. Samaratunga H; Delahunt B Pathology; 2012 Aug; 44(5):407-18. PubMed ID: 22777074 [TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical Differentiation of Plasmacytoid Urothelial Carcinoma From Secondary Carcinoma Involvement of the Bladder. Borhan WM; Cimino-Mathews AM; Montgomery EA; Epstein JI Am J Surg Pathol; 2017 Nov; 41(11):1570-1575. PubMed ID: 28786878 [TBL] [Abstract][Full Text] [Related]
11. Urothelial Carcinoma with shadow cell, lipid cell and sebaceous (skin adnexal) differentiation: Clinicopathological and immunohistochemical study of 10 cases. Behzatoğlu K Ann Diagn Pathol; 2015 Oct; 19(5):314-9. PubMed ID: 26235883 [TBL] [Abstract][Full Text] [Related]
12. Plasmacytoid urothelial carcinoma of the bladder. Lopez-Beltran A; Requena MJ; Montironi R; Blanca A; Cheng L Hum Pathol; 2009 Jul; 40(7):1023-8. PubMed ID: 19297008 [TBL] [Abstract][Full Text] [Related]
13. Invasive micropapillary urothelial carcinoma of the bladder. Lopez-Beltran A; Montironi R; Blanca A; Cheng L Hum Pathol; 2010 Aug; 41(8):1159-64. PubMed ID: 20381120 [TBL] [Abstract][Full Text] [Related]
14. Urothelial carcinoma of the bladder, lipid cell variant: clinicopathologic findings and LOH analysis. Lopez-Beltran A; Amin MB; Oliveira PS; Montironi R; Algaba F; McKenney JK; de Torres I; Mazerolles C; Wang M; Cheng L Am J Surg Pathol; 2010 Mar; 34(3):371-6. PubMed ID: 20139762 [TBL] [Abstract][Full Text] [Related]
16. Invasive urothelial carcinoma with chordoid features: a report of 12 distinct cases characterized by prominent myxoid stroma and cordlike epithelial architecture. Cox RM; Schneider AG; Sangoi AR; Clingan WJ; Gokden N; McKenney JK Am J Surg Pathol; 2009 Aug; 33(8):1213-9. PubMed ID: 19542871 [TBL] [Abstract][Full Text] [Related]
17. Epithelioid Angiosarcoma of the Bladder: A Series of 9 Cases. Matoso A; Epstein JI Am J Surg Pathol; 2015 Oct; 39(10):1377-82. PubMed ID: 25929352 [TBL] [Abstract][Full Text] [Related]
18. Large nested variant of urothelial carcinoma: a clinicopathological study of 36 cases. Compérat E; McKenney JK; Hartmann A; Hes O; Bertz S; Varinot J; Brimo F Histopathology; 2017 Nov; 71(5):703-710. PubMed ID: 28805264 [TBL] [Abstract][Full Text] [Related]
19. Is GATA3 expression maintained in regional metastases?: a study of paired primary and metastatic urothelial carcinomas. Zhao L; Antic T; Witten D; Paner GP; Taxy JB; Husain A; Gwin K; Mirza MK; Lingen MW; Tretiakova MS Am J Surg Pathol; 2013 Dec; 37(12):1876-81. PubMed ID: 24121175 [TBL] [Abstract][Full Text] [Related]
20. Detection of residual tumor cells in bladder biopsy specimens: pitfalls in the interpretation of cytokeratin stains. Tamas EF; Epstein JI Am J Surg Pathol; 2007 Mar; 31(3):390-7. PubMed ID: 17325480 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]